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Abstract 
Lipids are increasingly recognized as dynamic, critical metabolites affecting human physiology 
and pathophysiology. LIPID MAPS is a free resource dedicated to serving the lipid research 
community. 
 
Lipids play diverse roles in biology and are essential for life. They support energy metabolism, 
keep cells intact by forming impermeable membrane barriers, play roles in migration, apoptosis, 
autophagy, and cell division, and act as essential communicators in inflammation and immunity. 
Lipids are highly dynamic and are influenced by circadian rhythms, diet, age, lifestyle, drugs, 
disease, inflammation, and development. 
 In the emerging era of precision medicine, the biomedical world has now turned its attention to 
lipids in a major way. Lipids account for a large proportion of all metabolites, and their dynamic 
nature and complexity are fueling the promise that understanding their synthetic and degradative 
pathways, including fluxes, on a “global” or “big data” omics scale could revolutionize our 
ability to diagnose, stratify, and treat numerous acute and chronic conditions, including diabetes, 
infection, atherosclerosis, cancer, and autoimmunity. Lipidomics, in conjunction with 
transcriptomics, regulatory genomics, and proteomics, will provide deep insights into cellular 
and tissue function in health and pathophysiology. Lipids serve as endpoints of complex cellular 
and organ functions and represent key markers of normal and disease states. Because they are 
accessible from plasma and urine and can be fully quantified, lipids can be interrogated in a 
relatively noninvasive way, providing an opportunity for their integration with precision 
medicine methodologies that will emerge over the next 5 to 10 years (1-3). In addition, yet to be 
adequately addressed is the need to determine in which cellular membrane the measured changes 
in lipids occur; hopefully, developments in mass spectrometry imaging will progress in parallel. 
 
The number of researchers analyzing lipids in humans and animal models has massively 
increased. This burgeoning interest in lipid biology is leading to challenges in education and 
capacity, driving the need for new analytical, statistical, and informatic tools to study lipids. In 
the last 20 years, our knowledge of lipid biology and biochemistry has greatly expanded, at least 
in part due to the emergence of “user-friendly,” bench-top mass spectrometers. The combination 
of electrospray ionization (ESI) with high-pressure liquid chromatography (HPLC) or ultra-
performance liquid chromatography (UPLC) made lipid analysis accessible to a new generation 
of researchers. This has facilitated lipid research in new and exciting ways, with a high degree of 
sensitivity and selectivity that was previously impossible. Previously, the lipid research 
community consisted of a relatively small number of chemists and biochemists, who were highly 
collaborative, but had not yet been integrated into the much larger revolution in molecular 
biology and genomics that has evolved in recent years. 
 
In 2003, a $73M investment from the U.S. National Institutes of Health (NIH) supported the 
establishment of the LIPID MAPS effort (www.lipidmaps.org) led by Edward Dennis (UCSD), 
together with academic colleagues Alex Brown (Vanderbilt), Christian Glass (UCSD), Alfred 
Merrill (Georgia Tech), Robert Murphy (University of Colorado), Christian Raetz (Duke), David 
Russell (University of Texas, Southwestern), Michael van Nieuwenhze, (UCSD), Shankar 
Subramaniam (UCSD), Steven White (University of California, Irvine), and Joseph Witztum 
(UCSD), and industrial partner Walter Shaw, President of Avanti Polar Lipids. This initiative led 
directly to the coining of the term “lipidomics.” During the next ten years, LIPID MAPS, which 
stands for LIPID Metabolites And Pathways Strategy, played a major global role in driving the 
development of techniques and resources, including nomenclature standardization and 
supporting lipidomics to be ready for the emergence of the bioinformatics age. 
 
LIPID MAPS was focused at that time on developing mass spectrometry (MS) methods, 
applying them to the analysis of macrophages, generating isotope-labelled internal standards, and 
depositing data in a database for the global research community (4). The result was a manually 
curated database of around 40,000 structures, all classified and drawn using a standardized 
nomenclature and a structural drawing representation scheme developed by the consortium. The 
legacy of this work is a lipid classification and structural representation system used by virtually 
all lipid researchers and journals (5-7). In developing these tools, Dennis and colleagues 
purposefully reached out to the international community, inviting coauthors from Europe and 
Japan to join and provide input, which enabled them to succeed in developing a universally 
accepted system that enabled lipid researchers from around the world to communicate optimally 
and without controversy. 
 
In the last five years, increasing interest has attracted a new generation of scientists who view 
lipids in a very different way. Rather than working on individual species or classes of lipids, 
many younger scientists view lipids as part of the overall “big data” picture in a more holistic 
manner, in line with the developing era of systems biology. However, with this change, the need 
for biologists to have a basic grounding and knowledge in lipid biology and biochemistry is 
becoming even more essential if we are to make sense of the new data and harness the power of 
lipidomics fully to further our understanding of the roles of these diverse molecules in human 
health and disease. 
 
The LIPID MAPS NIH grant ended in 2014, and for the following three years, the database and 
website were maintained by Subramaniam with a legacy grant from NIH, which he coordinated 
with a sister  NIH grant from the Metabolomics Workbench 
(http://www.metabolomicsworkbench.org/). Without dedicated funding, the curation of new 
lipids would have ceased, and the continuation of the nomenclature work would have been 
stalled. In 2016, Valerie O’Donnell heard about this situation from her long-time collaborator 
Robert Murphy and realized that to lose LIPID MAPS would be devastating for lipidomics 
researchers around the world. Together with the original UCSD-led team and Michael Wakelam 
(Babraham Institute, Cambridge), Valerie led a successful bid to the Wellcome Trust for a 
£1.3M, 5-year Biomedical Resources Grant, which enabled the continuation of further 
development work on the database and website starting in 2017. This grant now funds LIPID 
MAPS as a multi-center international initiative, with curation, administration, and programming 
at Cardiff University (O’Donnell) and at the Babraham Institute in Cambridge (Wakelam) but 
retaining the original operational web and chemi-informatics team (led by Subramaniam) along 
with Dennis at UCSD. 
 
In early 2018, the database moved to Cambridge, a new web site was launched, which took into 
account feedback from the user community, curation was established in Cardiff, and the 
nomenclature and classification work continued. Working Groups, drawing on additional 
expertise, and the original members of the LIPID MAPS core groups were established and meet 
annually. To reflect the changes in global lipidomics needs, the Working Groups also include 
membership from two areas: pathways (with WikiPathways) and a new effort to harmonize and 
standardize lipidomics analysis and reporting (Lipidomics Standards Initiative). New 
nomenclature efforts are ongoing, reflecting the need to classify recently discovered lipid classes 
into the LIPID MAPS taxonomy. 
 
The research needs for lipidomics have evolved since 2003; however, the original challenges 
remain. For example, new nomenclature and curation is still needed because new lipids are 
constantly being discovered. The big questions remain: How many lipids do our cells contain? 
Can we come close to mapping them all? As MS instruments have become ever more powerful, 
our ability to survey the lipidome has increased; lipids that were undetectable 10 years ago are 
now discoverable. Of course, for new structures, there are major challenges in structural 
identification, which cannot be achieved by MS alone, and lipids present at picogram quantities 
in biological samples are undetectable by nuclear magnetic resonance (NMR) techniques. 
 
There is also an increasing need for data deposition, software tools, statistical pipelines, and 
network and pathway analysis, all of which reflect the changing nature of lipidomics. LIPID 
MAPS has implemented several initiatives in these areas, both directly on the site and with other 
resources. Data deposition has been established in partnership with the Metabolomics 
Workbench. Through LIPID MAPS, lipidomics researchers can either browse more than 500 
deposited datasets or deposit their own studies for data reuse by the global community. Direct 
links from our database entries to information held at complimentary resources, such as 
SwissLipids and MassBank of North America (MONA), support researchers who need as much 
information as possible about particular lipids to be discoverable in the same place. 
 
Software and statistical tools are increasingly needed for the analysis of big datasets. LIPID 
MAPS incorporated a suite of tools for generating volcano plots and undertaking multivariate 
analysis, as well as a software tool, LipidFinder, that removes artifactual signals from processed 
datasets generated by high-resolution MS (8). To aid re-use and improve discovery of resources, 
we provide a list of external lipidomics software that is continually expanding. Our previous 
VANTED pathways were migrated to WikiPathways (www.wikipathways.org) and a new 
network/pathway analysis tool is in development (9). This area is one of huge current growth 
and, working with Metabolomics Workbench, we plan to develop and implement additional tools 
to support the community. Structure drawing tools have long been supported by LIPID MAPS. 
We provide tools for researchers to generate all types of lipids, including a new suite for 
oxidized phospholipids. 
 
As more researchers study lipids, more analytical training and educational support are needed. 
To this end, we host instructional videos on lipid analysis methodologies introduced by Robert 
Murphy (Denver), and provide a series of curated protocols from the literature covering the 
analysis of lipid classes using LC/MS/MS. Bill Christie’s excellent LipidWeb, a veritable 
encyclopedia of lipids, is in the process of being migrated to LIPID MAPS for long-term hosting, 
and we are delighted to host Christie’s excellent weekly blog. Educational workshops are held, 
including at Keystone Symposia and a corresponding European Lipidomics Meeting in Leipzig 
in 2018. 
 
Where is the field of lipidomics headed in the next ten years? In terms of precision medicine 
approaches, two modalities are beginning to dominate cohort studies: high-resolution, “global” 
untargeted profiling and targeted quantitative methods, using tandem MS. Both have their pros 
and cons, and lipids present a specific challenge (unlike other metabolites) because an individual 
mass value can represent several different molecular species (isobars). This issue can be 
confusing to researchers new to lipid analytics and is a source of inaccuracy when reporting 
results; thus, some common guidelines for the community are needed. Global profiling is a 
powerful approach for screening and comparing large numbers of samples. However, it is less 
sensitive and not fully quantitative (low-abundance species are often missed), and validation is 
required. It can only identify “bulk” lipids, and isobars cannot be resolved (10). Its advantage 
over targeted methods is that it can be used to discover new lipids and can cover several different 
lipid classes in a single analysis. However, to know the fatty acyl composition, tandem MS, 
considered the “gold standard” approach, is needed. Tandem MS is the only modality that can 
approach truly quantitative lipidomics and is the most sensitive, enabling the detection of even 1 
pg of some lipids. However, targeted methods are generally optimized for single lipid classes 
only, making them relatively narrow and inflexible. 
 
Clinical-grade assays to quantify molecular species of lipids do not yet exist but will become 
increasingly required. These will need internationally agreed standardization and accreditation 
(for example, ISO standards) and will most likely be based on tandem MS. To support the 
standardization of lipidomics, LIPID MAPS has partnered with the Lipidomics Standards 
Initiative, a community-wide initiative led by Kim Ekroos (Lipidomics Consulting Ltd, Finland) 
and Gerhard Liebisch (University Hospital, Regensberg), which aims to generate guidelines for 
the major lipidomic workflows, including sample collection, storage, as well as data 
deconvolution and reporting (https://lipidomics-standards-initiative.org/). Through this 
collaboration, we will ensure that our database functions are fully aligned with the needs of the 
community, for example in line with providing “bulk” search interfaces and addressing the issue 
of isobars in a user-friendly manner. To accurately measure lipids, high-quality, isotope-labelled 
and primary lipid standards are essential. LIPID MAPS signposts have direct links to standards 
available from Avanti Polar Lipids and Cayman Chemical. The availability of standards tailored 
for specialized workflows is key and becoming more important as standardized/recommended 
approaches (for example, for plasma-based studies) begin to emerge. In addition, new lipids are 
being discovered all the time, and the need to identify and prioritize specific lipids most needed 
by the research community through our links with partner companies is an ongoing effort. 
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